A novel scoring system for precise severity quantification in severe fever with thrombocytopenia syndrome: development and application based on dynamic clinical data

Read full text Summarise with VIRAT
Authors: Yingchun Sun, Zhiyu Pan, Jing Sun, Yihui Sun, Wenjie Wang, Manman Liang, Aiping Zhang, Qiongle Wu, Haoyu Sheng, Jianghua Yang
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Severe Fever with Thrombocytopenia Syndrome (SFTS) is an acute infectious disease with high mortality. This study aimed to develop a quantitative scoring system for grading SFTS severity using dynamic clinical data. Methods A retrospective study included 547 confirmed SFTS patients from two hospitals. Clinical data were collected over a 14-day course (divided into four phases). Patients were grouped into survivors ( n = 451) and non-survivors ( n = 96). Statistical analyses, including Kaplan–Meier curves and log-rank tests, were performed. A prospective external validation cohort of 44 newly diagnosed patients was subsequently enrolled to validate the scoring system using C-statistic, calibration curves, and decision curve analysis (DCA). Results Of 547 patients, 96 (17.55%) were non-survivors. Multivariate logistic regression identified six independent prognostic factors across phases: age, platelet (PLT), aspartate aminotransferase (AST), and creatinine (Cr) (days 5–7); age, red blood cell distribution width (RDW), Cr, and lactate dehydrogenase (LDH) (days 8–10); Cr and LDH (days 11–14). A scoring system (0–11 points) was developed, stratifying patients into low (0–3), intermediate (4–7), and high (8–11) risk groups, with adverse outcome rates of 1.04, 22.92, and 76.04%, respectively. Kaplan–Meier curves showed significant prognostic differences (log-rank p < 0.001). External validation (44 cases) confirmed excellent performance: AUC 0.810–0.952, good calibration (Hosmer-Lemeshow p > 0.05), and net clinical benefit (DCA Eavg 0.068–0.098, Emax 0.422–0.559). Conclusion A dynamic SFTS severity scoring system was developed and validated. Internal and external validation confirmed its reliability and clinical utility, providing a simple, practical tool for timely assessment and early intervention.

Fields of Study & Subjects

Viral Infections and Vectors Sepsis Diagnosis and Treatment Viral Infections and Outbreaks Research

Publication details

Journal / source
Frontiers in Microbiology
Volume
17
Pages
1811615–1811615
Publication date
27 March 2026
Language
EN